Inventor
Tammy C. Wang
Inventor
Lawrenceville, NJ, US
Overview
Patents· 31 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
A61KPreparations for medical, dental or toiletry purposes5%
G01BMeasuring length, thickness or similar linear dimensions1%
H04NPictorial communication, e.g. television1%
PatentTitleYear
10,917,617Tunnel deformation monitoring system202110,173,991Sulfone amide linked benzothiazole inhibitors of endothelial lipase20199,540,323'7-hydroxy-indolinyl antagonists of P2Y1 receptor'20179,428,504'7-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptor'20169,394,260'Pyrimidinone carboxamide inhibitors of endothelial lipase'20169,249,096'Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors'20169,199,946'Pyrimidinone carboxamide inhibitors of endothelial lipase'20159,169,240'Ketone linked benzothiazole inhibitors of endothelial lipase'20159,139,578'Amide or urea containing benzothiazole inhibitors of endothelial lipase'20159,120,794'Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors'20158,993,557'Pyridinedione carboxamide inhibitors of endothelial lipase'20158,987,314'Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase'20158,952,180'Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors'20158,946,430'Quinolinone carboxamide inhibitors of endothelial lipase'20158,933,235'Pyridinedione carboxamide inhibitors of endothelial lipase'20158,680,090'Sulfonyl containing benzothiazole inhibitors of endothelial lipase'20148,642,576'Heterocyclic CETP inhibitors'20148,329,718'N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20128,304,403'Heterocyclic CETP inhibitors'20127,888,376'Heterocyclic CETP inhibitors'20117,790,770'Heterocyclic CETP inhibitors'20107,772,267'Bicyclic modulators of androgen receptor function'20107,728,008'N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20107,674,828'Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions'20107,625,923'Bicyclic modulators of androgen receptor function'20097,550,499'Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20097,405,234'Bicyclic modulators of androgen receptor function'20087,388,021'Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'20087,205,318'Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors'20076,992,102'Bicyclic modulators of androgen receptor function'20066,670,386'Bicyclic modulators of androgen receptor function'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2019Patents assigned to BRISTOL MYERS SQUIBB CO (30)· patent assignee history
2003–2019Based in Lawrenceville, NJ, US· patent location history
2012–2014Patents assigned to QIAO JENNIFER X (3)· patent assignee history
2012–2014Patents assigned to WANG TAMMY C (3)· patent assignee history
2012–2014Patents assigned to CHEN BANG-CHI (2)· patent assignee history
2012–2014Patents assigned to FINLAY HEATHER (2)· patent assignee history
2021Based in Guangdong, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 30 | 2003–2019 |
| QIAO JENNIFER X | 3 | 2012–2014 |
| WANG TAMMY Cself | 3 | 2012–2014 |
| CHEN BANG-CHI | 2 | 2012–2014 |
| FINLAY HEATHER | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lawrenceville, New Jersey, US | 30 | 2003–2019 |
| Guangdong, CN | 1 | 2021 |